This week, we will discuss the STOP ACEi trial, a poster from Kidney Week but published in the NEJM. Should we stop RAS inhibition at an arbitrary GFR or bravely carry on?
The STOP ACEi Trial - Visual Abstract
Does the discontinuation of RAS inhibitors improve eGFR in patients with advanced CKD? NSMC Intern Dana Larsen explains it graphically.
Nikhil has some thoughts on the Situation at Twitter
NephJC has moved newsletter hosts...again
Flozins strike again!
If you missed the biggest NephJC of the year, at least read the highlights here.
The future for refractory lupus nephritis?
Ten Tweet round up of exciting CAR T trial in patients with SLE discussed last month - check it out while you can!
The EMPA-KIDNEY Visual Abstract
EMPA-Kidney: ‘Empa’sizing the role of Flozins in Chronic Kidney Disease
Keep Calm and #AskRenal
ASN Innovations in Kidney Education Contest winners
The 2022 NephJC Kidneys Award Winners
KidneyWk 2022 BINGO
Get the original #KidneyWk Bingo Board here (PDF).
We are not responsible if you get kicked out for yelling “BINGO!”
#KidneyWk is Here!
What does the future look like in ADPKD?
Basic science week - catch up in only Ten Tweets here.
Is the horse before the CAR T in SLE?
Is Anti-CD19 CAR T Cell therapy helpful in refractory SLE? The Visual Abract
Is Anti-CD19 CAR T Cell therapy an efficacious and tolerable option for refractory SLE?
NSMC intern Susan Thanabalasingam explains it graphically
mRNA cis-inhibition in PKD progression - The Visual Abstract
NSMC intern Sandhya Suresh simplifies the role of mRNA cis-inhibition in PKD progression via a lucid visual abstract
